XML 14 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities:    
Consolidated net income (loss) $ 72,063 $ (4,103)
Adjustments to reconcile consolidated net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 15,615 14,016
Stock-based compensation expense 12,420 11,245
Loss on disposal of fixed assets 839 0
Provision for doubtful accounts 7 0
Litigation-contingency expense 0 19,500
Decrease in long-term deferred revenue 0 (1,020)
Decrease in other assets 1,459 788
Deferred income taxes (4) 5
Increase (decrease) in long-term income taxes payable 43 (312)
Change in current assets and liabilities, net 21,398 606
Net cash provided by operating activities 123,840 40,725
Investing activities:    
Additions to property, plant and equipment and internal-use software (14,775) (21,866)
Net cash used for investing activities (14,775) (21,866)
Financing activities:    
Proceeds from employee stock plans 8,935 7,047
Repurchases of Common Stock (32,978) (497)
Net cash (used for) provided by financing activities (24,043) 6,550
Effect of foreign exchange rates on cash 87 (23)
Net increase in cash and cash equivalents 85,109 25,386
Cash and cash equivalents at beginning of period 277,273 242,219
Cash and cash equivalents at end of period 362,382 267,605
Supplemental disclosure:    
Purchases of property, plant and equipment and internal-use software incurred but not yet paid $ 1,862 $ 2,976